Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7034-7038

  Byun, D S ^a   Lee, M G ^a   Chae, K S ^a   Ryu, B G ^a   Chi, S G ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; BREAST CANCER; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; STOMACH ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CHROMOSOMES, HUMAN, PAIR 3; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NEOPLASM PROTEINS; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035476236     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gastric carcinoma
2. Gastric adenocarcinoma: Pathomorphology and molecular pathology
3. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas
4. Allelotype of gastric adenocarcinoma
5. Fractional allelic loss in gastric carcinoma correlates with growth patterns
6. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines
7. Loss of FHIT expression in gastric carcinoma
8. Histological and molecular mapping of adenocarcinoma of the oesophagus and gastroesophageal junction: Loss of heterozygosity occurs in histologically normal epithelium in the oesophagus and stomach
9. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
10. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
11. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
12. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
13. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma
14. A novel family of Ras-association domains
15. Identification of Norel as a potential Ras effector
16. Substrate specificities and identification of putative substrates of ATM kinase family members
17. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
18. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras
19. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis
20. p53 in prostate: Frequent expressed transition mutations
21. INK4A/MTSI) expression in human primary prostate carcinomas
22. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease
23. Loss of imprinting and elevated expression of wild type p73 in human gastric adenocarcinoma
24. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
25. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene